Impact of quality management systems implementation on cost and competitiveness in Palestinian pharmaceutical companies

مقدم أطروحة جامعية

Abu al-Rubb, Ziyad

مشرف أطروحة جامعية

Najm, Mundhir

أعضاء اللجنة

Abd al-Karim, Nasir
Taha, Abd al-Rauf

الجامعة

جامعة بيرزيت

الكلية

كلية الأعمال و الاقتصاد

القسم الأكاديمي

دائرة إدارة الأعمال

دولة الجامعة

فلسطين (الضفة الغربية)

الدرجة العلمية

ماجستير

تاريخ الدرجة العلمية

2005

الملخص الإنجليزي

The pharmaceutical industry is one of the most important sectors because pharmaceutical products are used for human health.

So, this sector is in general, heavily regulated to ensure that they are fit for their intended use, comply with the requirements and do not place patients at risk due to inadequate safety, quality or efficacy.

The attainment of this quality objective is the responsibility of senior management and requires the participation and commitment by staff in many different departments and at all levels within the company, by the company’s suppliers and by the distributors.

To achieve the quality objective reliably there must be a comprehensively designed and correctly implemented system of Quality Assurance incorporating Good Manufacturing Practice and thus Quality Control.

There is a severe competition in the pharmaceutical industry all over the world, and there is increasing of costs related to production, research and development, etc.

Like, other markets all over the world, there is sever pharmaceutical competition in Palestinian market.

There are three types of companies competing in the Palestinian market regarding to their origin, Palestinian companies, Israeli companies, and International companies.

Palestinian pharmaceutical companies face many challenges, such as, competition between each other's, competition with Israeli companies, and with International companies, complying with international standards and regulations, and cost reduction.

Palestinian pharmaceutical companies started focusing and working to comply with and to produce according to international regulations such as, FDA-camp, EUGMP, and WHO- GMP since the beginning of 1990s.

So, they started to invest in improving quality, in order to face the local competition and to seek for opportunities for exporting their products.

They have implemented ISO9000, and ISO 14000, and they are trying to get the certificate of Good Manufacturing Practices (GMP).

The purpose of this study was to investigate the pharmaceutical companies' commitment to improving quality, to investigate the correlation between quality management systems and cost, and to investigate the correlation between quality management systems and competitiveness.

The study used various methods to collect the data and test the hypotheses, such as the literature review, the questionnaire, and interviews.

The results proved that there is commitment for improving quality, in order to face competition in the local market and compete globally, after getting GMP certificate.

Moreover, the study showed that a correlation exists between quality improvement and cost reduction, and, it showed that correlation exists between quality and competitiveness.

التخصصات الرئيسية

إدارة الأعمال

الموضوعات

• المنافسة
• مراقبة التكاليف
• فلسطين
• الجوانب الاقتصادية
• إدارة الجودة الشاملة

عدد الصفحات

161

قائمة المحتويات

• APA
• MLA
• AMA

لغة النص

الإنجليزية

نوع البيانات

رسائل جامعية

رقم السجل

BIM-301984